BCBalvin H. L. Chua

Balvin H. L. Chua

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Balvin H. L. Chua has a total of 18 co-authors. Here are the top co-authors by number of shared publications:

  • Ronald C. Hamdy

    Cecile Cox Quillen Laboratory of Geriatrics, James H. Quillen School of Medicine, East Tennessee State University, Johnson City, TN 37614, USA

    5 shared publications
  • Xingshun Xu

    Department of Neurology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China

    4 shared publications
  • Chu C. Chua

    Cecile Cox Quillen Laboratory of Geriatrics, James H. Quillen School of Medicine, East Tennessee State University, Johnson City, TN 37614, USA

    3 shared publications
  • Jinping Gao

    Cecile Cox Quillen Laboratory of Geriatric Research, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN

    3 shared publications
  • Chu Chang Chua

    Cecile Cox Quillen Laboratory of Geriatrics, James H. Quillen School of Medicine, East Tennessee State University, Johnson City, TN 37614, USA

    2 shared publications
  • Hong Wang

    Cecile Cox Quillen Laboratory of Geriatrics, James H. Quillen School of Medicine, East Tennessee State University, Johnson City, TN 37614, USA

    2 shared publications

Latest Publications

  • Synergistic protective effects of humanin and necrostatin-1 on hypoxia and ischemia/reperfusion injury

    by Xingshun Xu, Kao-Wei Chua, Chu C. Chua, Chun-Feng Liu, Ronald C. Hamdy, Balvin H.L. Chua


  • Prevention of ischemia/reperfusion‐induced cardiac apoptosis and injury by melatonin is independent of glutathione peroxdiase 1

    by Zhongyi Chen, Chu C. Chua, Jinping Gao, Kao‐Wei Chua, Ye‐Shih Ho, Ronald C. Hamdy, Balvin H. L. Chua

    Abstract:  Free‐radical generation is one of the primary causes of myocardial ischemia/reperfusion (I/R) injury. Melatonin is an efficient free‐radical scavenger and induces the expression of antioxidant enzymes. We have previously shown that melatonin can prevent free‐radical‐induced myocardial injury. To date, the mechanism underlying melatonin’s cardioprotective effect is not clear. In this study, we assessed the ability of melatonin to protect against I/R injury in mice deficient in glutathione peroxidase 1 (Gpx1). Mice hearts were subjected to 40 min of global ischemia in vitro followed by 45 min of reperfusion. Myocardial I/R injury (expressed as % of recovery of left ventricular developed pressure × heart rate) was exacerbated in mice deficient in Gpx1 (51 ± 3% for Gpx1+/+ mice versus 31 ± 6% for Gpx1−/− mice, P < 0.05). Administration of melatonin for 30 min protected against I/R injury in both Gpx1+/+ mice (72 ± 4.8%) and Gpx1−/− mice (63 ± 4.7%). This protection was accompanied by a significant improvement in left ventricular end‐diastolic pressure and a twofold decrease in lactate dehydrogenase (LDH) level released from melatonin‐treated hearts. In another set of experiments, mice were subjected to 50 min of ligation of the left descending anterior coronary artery in vivo followed by 4 hr of reperfusion. The infarct sizes, expressed as the percentage of the area at risk, were significantly larger in Gpx1−/− mice than in Gpx1+/+ mice (75 ± 9% versus 54 ± 6%, P < 0.05) and were reduced significantly in melatonin‐treated mice (31 ± 3.7% Gpx1−/− mice and 33 ± 6.0% Gpx1+/+ mice). In hearts subjected to 30 min of coronary artery occlusion followed by 3 hr of reperfusion, melatonin‐treated hearts had significantly fewer in situ oligo ligation‐positive myocytes and less protein nitration. Our results demonstrate that the cardioprotective function of melatonin is independent of Gpx1.


  • Open Access

    Over-expression of a modified bifunctional apoptosis regulator protects against cardiac injury and doxorubicin-induced cardiotoxicity in transgenic mice

    by Chu Chang Chua, Jinping Gao, Ye-Shih Ho, Xingshun Xu, I-Chun Kuo, Kaw-Yan Chua, Hong Wang, Ronald C. Hamdy, John C. Reed, Balvin H.L. Chua

    Bifunctional apoptosis regulator (BAR) is an endoplasmic reticulum protein that interacts with both the extrinsic and intrinsic apoptosis pathways. We hypothesize that over-expression of BARΔRING prevents apoptosis and injury following ischaemia/reperfusion (I/R) and attenuates doxorubicin (DOX)-induced cardiotoxicity. We generated a line of transgenic mice that carried a human BARΔRING transgene under the control of the mouse α-myosin heavy chain promoter. The RING domain, which binds ubiquitin conjugating enzymes, was deleted to prevent auto-ubiquitination of BAR and allow accumulation of the BAR protein, which binds apoptosis-regulating proteins. High levels of human BARΔRING transcripts and 42 KDa BARΔRING protein were expressed in the hearts of transgenic mice. When excised hearts were reperfused ex vivo for 45 min as Langendorff preparations after 45 min of global ischaemia, the functional recovery of the hearts, expressed as left ventricular developed pressure × heart rate, was 23 ± 1.7% in the non-transgenic hearts compared with 51.5 ± 4.3% in the transgenic hearts (P < 0.05). For in vivo studies, mice were subjected to 50 min of ligation of the left descending anterior coronary artery followed by 4 h of reperfusion. The infarct sizes following I/R injury, expressed as the percentage of the area at risk, were significantly smaller in the transgenic mice than in the non-transgenic mice (29 ± 4 vs. 55 ± 4%, P < 0.05). In hearts of mice subjected to cardiac I/R injury, BAR transgenic hearts had significantly fewer in situ oligo-ligation-positive cardiac cells (5.0 ± 0.4 vs. 13.4 ± 0.5%, P < 0.05). Over-expression of BARΔRING also significantly attenuated DOX-induced cardiac dysfunction and apoptosis. Our results demonstrate that over-expression of BARΔRING renders the heart more resistant to I/R injury and DOX-induced cardiotoxicity, and this protection correlates with reduced cardiomyocyte apoptosis.


  • Neuroprotective effect of humanin on cerebral ischemia/reperfusion injury is mediated by a PI3K/Akt pathway

    by Xingshun Xu, Chu Chang Chua, Jinping Gao, Kao-Wei Chua, Hong Wang, Ronald C. Hamdy, Balvin H.L. Chua


  • Necrostatin‐1 protects against glutamate‐induced glutathione depletion and caspase‐independent cell death in HT‐22 cells

    by Xingshun Xu, Chu C. Chua, Jiming Kong, Richard M. Kostrzewa, Udayasankar Kumaraguru, Ronald C. Hamdy, Balvin H. L. Chua

    Glutamate, a major excitatory neurotransmitter in the CNS, plays a critical role in neurological disorders such as stroke and Parkinson’s disease. Recent studies have suggested that glutamate excess can result in a form of cell death called glutamate‐induced oxytosis. In this study, we explore the protective effects of necrostatin‐1 (Nec‐1), an inhibitor of necroptosis, on glutamate‐induced oxytosis. We show that Nec‐1 inhibits glutamate‐induced oxytosis in HT‐22 cells through a mechanism that involves an increase in cellular glutathione (GSH) levels as well as a reduction in reactive oxygen species production. However, Nec‐1 had no protective effect on free radical‐induced cell death caused by hydrogen peroxide or menadione, which suggests that Nec‐1 has no antioxidant effects. Interestingly, the protective effect of Nec‐1 was still observed when cellular GSH was depleted by buthionine sulfoximine, a specific and irreversible inhibitor of glutamylcysteine synthetase. Our study further demonstrates that Nec‐1 significantly blocks the nuclear translocation of apoptosis‐inducing factor (a marker of caspase‐independent programmed cell death)and inhibits the integration of Bcl‐2/adenovirus E1B 19 kDa‐interacting protein 3 (a pro‐death member of the Bcl‐2 family) into the mitochondrial membrane. Taken together, these results demonstrate for the first time that Nec‐1 prevents glutamate‐induced oxytosis in HT‐22 cells through GSH related as well as apoptosis‐inducing factor and Bcl‐2/adenovirus E1B 19 kDa‐interacting protein 3‐related pathways.